Topic: data transparency

Most of the top noncommercial funders of clinical trials have no policies that mandate the eventual reporting of study results, Alltrials says.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

Rare disease biopharma Shire has kick-started a new mandatory open-access program for research manuscripts to journals it has funded.

GlaxoSmithKline’s long-standing president of R&D, Patrick Vallance, is said to be standing down.

A BMJ paper has shown that progress is being made on clinical trial transparency, although there is still a way to go.

After a long and often controversial battle for transparency, the European Medicines Agency will from today become the first regulator to publish clinical study reports in a step toward opening up clinical trial data.

Clinical trial transparency is the name of the game with a new site launched this week aimed at allowing everyone to “locate, match, and share all publicly accessible data and documents” around medicines studies.

Two clinicians have devised a new system to prevent clinical trial documents being secretly altered to make new drugs look more effective than they are by using a similar system as the digital currency of bitcoin.